By John K. Waters
A new generation of artificial intelligence models trained on tumor-specific somatic mutations is demonstrating potential to transform cancer care by predicting prognosis and optimizing therapeutic choices based on individual patient profiles.
Read Now
By John K. Waters
Researchers at Microsoft's AI for Good Lab and the University of Washington have developed an artificial intelligence model that could reduce false positives in breast cancer screening while providing clearer explanations for its decisions.
Read Now
By John K. Waters
Alphabet's Isomorphic Labs says it's nearly ready to begin clinical trials on drugs designed entirely with artificial intelligence, a move that could reshape how new medicines are developed, but still faces a long and uncertain road ahead.
Read Now
By John K. Waters
Swiss health technology company Aktiia has received FDA 510(k) clearance for its G0 Blood Pressure Monitoring System, becoming the first cuffless blood pressure monitor approved for over-the-counter use in the United States.
Read Now
By John K. Waters
A new diagnostic system developed by Microsoft AI researchers has outperformed practicing physicians in a series of complex clinical cases, offering a glimpse into how generative artificial intelligence could transform high-stakes medical decision making.
Read Now
By John K. Waters
Johnson & Johnson MedTech, the company's medical technology division has established a new artificial intelligence fund aimed at advancing surgical applications, partnering with Nvidia and Amazon Web Services to evaluate proposals and provide technical resources.
Read Now
By John K. Waters
Software platform provider Vantiq has formed a partnership with consulting firm Huron to implement artificial intelligence systems in hospital operations, starting with command centers that manage critical healthcare functions.
Read Now
By John K. Waters
Stand Up to Cancer (SU2C) has announced a partnership with technology firm SandboxAQ aimed at accelerating the development of cancer treatments through advanced artificial intelligence tools.
Read Now
By John K. Waters
SIME Diagnostics, a UK-based medical technology firm, has completed a clinical study evaluating an artificial intelligence-powered Lung Maturity Test (LMT) designed to identify respiratory risks in late-preterm newborns in the United States.
Read Now
By John K. Waters
OpenAI launches HealthBench, a massive new benchmark that's the company's first major independent health care project.
Read Now